By Piero Bindi, Associate Director eCOA Library, IQVIA eCOA
The pharmaceutical industry is continuing to shift towards a more patient-centric drug development landscape and patient reported outcomes are increasingly becoming an important benchmark for regulators and payers to measure the quality of a new treatment. This shift has made Clinical Outcome Assessments (COAs) an increasingly necessary and often required tool to gather patient experience data in most trials today.
Electronic Clinical Outcome Assessments (eCOAs) offer a direct line to patients, capturing real-time insights about their experience with their disease, the trial, and a treatment’s impact on their quality of life. These digital tools provide patients a chance to be heard while providing sponsors with quantitative and qualitative data to track the influence and efficacy of a treatment.
However, creating and validating a COA in an electronic format from scratch for each study is a cumbersome process that can add months to the trial planning process, and even small errors can lead to costly setbacks.